PHKA2 encodes the liver isoform of the alpha regulatory subunit of phosphorylase kinase (PhK). PhK is a large hexadecameric (alpha-beta-gamma-delta)4 holoenzyme in which the gamma subunit (PHKG1 in muscle, PHKG2 in liver) is the catalytic serine/threonine kinase and the large alpha (PHKA1/PHKA2) and beta (PHKB) subunits are regulatory; the delta subunit is calmodulin, conferring Ca2+ sensitivity. PHKA2 is itself non-catalytic: as a regulatory subunit it is a target of cAMP-dependent (PKA) phosphorylation which, together with Ca2+/calmodulin, relieves inhibition and activates the catalytic gamma subunit. The activated holoenzyme phosphorylates glycogen phosphorylase (b to a), triggering glycogenolysis; PhK thereby couples hormonal and neural signals to hepatic glycogen breakdown. PHKA2 binds calmodulin and acts in the cytosol. Loss-of-function variants in PHKA2 cause X-linked liver phosphorylase kinase deficiency (glycogen storage disease type IXa, GSD9A), the most common form of PhK deficiency, characterized by hepatomegaly and growth retardation that are usually mild and improve with age.
| GO Term | Evidence | Action | Reason |
|---|---|---|---|
|
GO:0005964
phosphorylase kinase complex
|
IBA
GO_REF:0000033 |
ACCEPT |
Summary: Phylogenetically inferred membership in the phosphorylase kinase complex. This is the defining, core cellular-component assignment for PHKA2 as the liver alpha regulatory subunit of the (alpha-beta-gamma-delta)4 holoenzyme.
Reason: Strongly supported: PHKA2 is one of the alpha subunits of the phosphorylase kinase holoenzyme. UniProt SUBUNIT describes the complex composition and assigns alpha/beta as regulatory subunits, consistent with this IBA assignment.
Supporting Evidence:
file:human/PHKA2/PHKA2-uniprot.txt
beta, gamma, and delta subunits. Alpha (PHKA1 or PHKA2) and beta (PHKB)
|
|
GO:0004689
phosphorylase kinase activity
|
IEA
GO_REF:0000117 |
MARK AS OVER ANNOTATED |
Summary: ARBA electronic assertion that PHKA2 enables phosphorylase kinase activity. This is the activity of the holoenzyme, catalyzed by the gamma subunit (PHKG1/PHKG2); the alpha subunit is regulatory and non-catalytic.
Reason: The catalytic phosphorylase kinase activity resides in the gamma subunit, not the alpha regulatory subunit. UniProt states that alpha and beta are regulatory subunits while gamma is the catalytic subunit, so an 'enables' assertion of the holoenzyme kinase activity on PHKA2 over-attributes catalysis to a regulatory chain. PHKA2 contributes to this holoenzyme activity as a complex member (captured in core_functions via contributes_to_molecular_function) but does not independently enable it.
Supporting Evidence:
file:human/PHKA2/PHKA2-uniprot.txt
are regulatory subunits, gamma (PHKG1 or PHKG2) is the catalytic
|
|
GO:0005516
calmodulin binding
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based assertion of calmodulin binding. This is a genuine molecular function of the alpha subunit: UniProt notes the alpha chain may bind calmodulin and annotates two calmodulin-binding regions (807-837, 1059-1099).
Reason: Well supported and biologically informative for the alpha subunit. Consistent with the Calmodulin-binding keyword and two annotated calmodulin-binding regions. Calmodulin is the delta subunit of the complex, so alpha-CaM binding is functionally central to Ca2+ regulation of the holoenzyme.
Supporting Evidence:
file:human/PHKA2/PHKA2-uniprot.txt
The alpha chain may
file:human/PHKA2/PHKA2-uniprot.txt
bind calmodulin.
|
|
GO:0005737
cytoplasm
|
IEA
GO_REF:0000117 |
ACCEPT |
Summary: ARBA electronic assertion of cytoplasmic localization. Correct but non-specific; the more precise, curatorially supported location is the cytosol (GO:0005829).
Reason: Cytoplasm is a correct broad parent of the cytosol, where the phosphorylase kinase complex acts on cytosolic glycogen phosphorylase. Retained as a valid, if less specific, location; the cytosol annotation is the more informative one.
|
|
GO:0005886
plasma membrane
|
IEA
GO_REF:0000044 |
MARK AS OVER ANNOTATED |
Summary: Subcellular-location keyword mapping (SL-0039) derived from UniProt's Cell membrane assignment, which is itself an ECO:0000305 (inference from prenylation) annotation, not an experimental localization.
Reason: The UniProt Cell membrane / Lipid-anchor location is an ECO:0000305 inference resting on a possible C-terminal farnesyl-cysteine (itself by-similarity, ECO:0000250), with the PTM note stating the terminal tripeptide is 'probably not removed'. The functionally relevant and better-supported compartment is the cytosol, where the complex phosphorylates cytosolic glycogen phosphorylase. Retained but flagged as a weakly supported, likely over-annotated location.
Supporting Evidence:
file:human/PHKA2/PHKA2-uniprot.txt
SUBCELLULAR LOCATION: Cell membrane
|
|
GO:0005975
carbohydrate metabolic process
|
IEA
GO_REF:0000002 |
ACCEPT |
Summary: InterPro-based involvement in carbohydrate metabolism. Correct but broad; PHKA2 participates specifically in glycogen catabolism as part of the phosphorylase kinase complex.
Reason: Accurate high-level biological-process assignment. The more specific glycogen metabolic / glycogen catabolic terms better capture the function and are reflected in core_functions, but this broad parent is not incorrect.
|
|
GO:0005977
glycogen metabolic process
|
IEA
GO_REF:0000120 |
ACCEPT |
Summary: Combined-IEA/UniPathway involvement in glycogen metabolism. Accurate: the phosphorylase kinase complex regulates hepatic glycogenolysis, and PHKA2 deficiency causes a glycogen storage disease.
Reason: Well aligned with the gene's biology. UniProt PATHWAY records glycogen metabolism, and PHKA2 loss-of-function causes glycogen storage disease type IXa. The catabolic direction is captured more specifically in core_functions.
Supporting Evidence:
file:human/PHKA2/PHKA2-uniprot.txt
PATHWAY: Glycan biosynthesis; glycogen metabolism.
|
|
GO:0005515
protein binding
|
IPI
PMID:23455922 Interlaboratory reproducibility of large-scale human protein... |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding annotation from a large-scale AP-MS protein-complex interlaboratory reproducibility study. Uninformative term with no specific, functionally interpreted partner recorded.
Reason: 'Protein binding' (GO:0005515) is an uninformative molecular-function term. The supporting reference is a high-throughput interactome dataset that does not characterize a specific PHKA2 function; the biologically meaningful partners (PHKG2, PHKB) are already captured by the phosphorylase kinase complex annotation. Per curation policy this experimental IPI is marked as over-annotated rather than removed.
|
|
GO:0005515
protein binding
|
IPI
PMID:26496610 A human interactome in three quantitative dimensions organiz... |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding annotation from a quantitative human-interactome study. Uninformative term with no specific functional partner recorded.
Reason: Uninformative 'protein binding' term derived from a large-scale interactome dataset. No specific PHKA2 function is established. Marked as over-annotated per curation policy rather than removed.
|
|
GO:0005515
protein binding
|
IPI
PMID:28514442 Architecture of the human interactome defines protein commun... |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding annotation from a large-scale interactome/protein-community study. Uninformative term.
Reason: Uninformative 'protein binding' term from a high-throughput interactome dataset; no specific PHKA2 molecular function is established. Marked over-annotated per policy rather than removed.
|
|
GO:0005515
protein binding
|
IPI
PMID:32296183 A reference map of the human binary protein interactome. |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding annotation from a binary (Y2H) reference-interactome map. Uninformative term.
Reason: Uninformative 'protein binding' term from a large-scale binary interactome screen. No specific, functionally interpreted PHKA2 partner is captured beyond complex membership already annotated elsewhere. Marked over-annotated per policy.
|
|
GO:0005515
protein binding
|
IPI
PMID:32707033 Kinase Interaction Network Expands Functional and Disease Ro... |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding annotation from a kinase-interaction-network study. The relevant kinase partner (PHKG2, the catalytic gamma subunit) reflects complex membership, but the bare term itself is uninformative.
Reason: Uninformative 'protein binding' term. The functionally meaningful interaction (with the catalytic gamma subunit PHKG2) is captured by the phosphorylase kinase complex annotation; the bare MF term adds nothing. Marked over-annotated per policy rather than removed.
|
|
GO:0005515
protein binding
|
IPI
PMID:32814053 Interactome Mapping Provides a Network of Neurodegenerative ... |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding annotation from a neurodegenerative-disease interactome mapping study (partner SPRED1). Uninformative term.
Reason: Uninformative 'protein binding' term from a high-throughput interactome dataset; the SPRED1 interaction is not functionally interpreted for PHKA2. Marked over-annotated per policy rather than removed.
|
|
GO:0005515
protein binding
|
IPI
PMID:33961781 Dual proteome-scale networks reveal cell-specific remodeling... |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding annotation from a proteome-scale, cell-specific interactome study. Uninformative term.
Reason: Uninformative 'protein binding' term from a large-scale interactome dataset; no specific PHKA2 function is established. Marked over-annotated per policy.
|
|
GO:0005515
protein binding
|
IPI
PMID:35271311 OpenCell: Endogenous tagging for the cartography of human ce... |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding annotation from the OpenCell endogenous-tagging cellular cartography study. Uninformative term.
Reason: Uninformative 'protein binding' term from a high-throughput cellular-organization dataset; no specific PHKA2 molecular function is established. Marked over-annotated per policy rather than removed.
|
|
GO:0005515
protein binding
|
IPI
PMID:40205054 Multimodal cell maps as a foundation for structural and func... |
MARK AS OVER ANNOTATED |
Summary: Bare protein-binding annotation from a multimodal cell-maps structural/functional genomics study. Uninformative term.
Reason: Uninformative 'protein binding' term from a large-scale cell-mapping dataset; no specific PHKA2 function is established. Marked over-annotated per policy rather than removed.
|
|
GO:0005964
phosphorylase kinase complex
|
IEA
GO_REF:0000107 |
ACCEPT |
Summary: Ensembl-Compara orthology transfer of experimentally verified phosphorylase kinase complex membership. Consistent with the core complex assignment.
Reason: Correct and well supported; the same defining complex membership as the IBA and TAS annotations. PHKA2 is the liver alpha regulatory subunit of the holoenzyme.
Supporting Evidence:
file:human/PHKA2/PHKA2-uniprot.txt
Hexadecamer of 4 heterotetramers, each composed of alpha,
|
|
GO:0005829
cytosol
|
TAS
Reactome:R-HSA-71588 |
ACCEPT |
Summary: Reactome-curated cytosolic localization. The cytosolic phosphorylase kinase complex phosphorylates cytosolic glycogen phosphorylase (PYGL) in liver. This is the core, functionally relevant location for PHKA2.
Reason: Well supported by Reactome curation of the hepatic glycogenolysis reaction; the complex containing PHKA2 acts in the cytosol. This is the preferred location over the by-similarity plasma-membrane assignment.
|
|
GO:0004689
phosphorylase kinase activity
|
TAS
PMID:7549948 Isolation of cDNA encoding the human liver phosphorylase kin... |
MARK AS OVER ANNOTATED |
Summary: Author-statement (TAS) assignment of phosphorylase kinase activity from the paper cloning the human liver PHKA2 alpha subunit. The described activity is that of the PhK holoenzyme, catalyzed by the gamma subunit; the alpha subunit is regulatory.
Reason: The cited paper isolates and characterizes the liver alpha subunit and discusses liver phosphorylase kinase (the holoenzyme), but the catalytic activity resides in the gamma subunit. Assigning 'enables phosphorylase kinase activity' to the regulatory alpha subunit over-attributes catalysis. PHKA2 contributes to this holoenzyme activity as a complex member (contributes_to_molecular_function in core_functions) but does not independently enable it.
Supporting Evidence:
PMID:7549948
We isolated and determined the structure of human liver alpha subunit of PHK (PHKA2) cDNA.
|
|
GO:0005964
phosphorylase kinase complex
|
TAS
PMID:7549948 Isolation of cDNA encoding the human liver phosphorylase kin... |
ACCEPT |
Summary: Author-statement (TAS) assignment of phosphorylase kinase complex membership from the paper cloning the human liver PHKA2 alpha subunit. Core complex membership.
Reason: Directly supported: the reference characterizes PHKA2 as the human liver alpha subunit of phosphorylase kinase, establishing its membership in the holoenzyme complex.
Supporting Evidence:
PMID:7549948
We isolated and determined the structure of human liver alpha subunit of PHK (PHKA2) cDNA.
|
|
GO:0005975
carbohydrate metabolic process
|
TAS
PMID:7549948 Isolation of cDNA encoding the human liver phosphorylase kin... |
ACCEPT |
Summary: Author-statement involvement in carbohydrate metabolism. Correct but broad; the specific process is glycogen catabolism via the phosphorylase kinase complex.
Reason: Accurate high-level assignment supported by the paper's framing of PHKA2 in liver glycogenosis. More specific glycogen catabolic terms are captured in core_functions, but this broad parent is not incorrect.
Supporting Evidence:
PMID:7549948
deficiency is the most frequent liver glycogen storage disease.
|
|
GO:0006091
generation of precursor metabolites and energy
|
TAS
PMID:7549948 Isolation of cDNA encoding the human liver phosphorylase kin... |
KEEP AS NON CORE |
Summary: Author-statement involvement in generation of precursor metabolites and energy. This reflects the downstream role of hepatic glycogenolysis in supplying glucose for energy, an indirect/downstream consequence rather than PHKA2's core function.
Reason: Glycogenolysis driven by the phosphorylase kinase complex ultimately supplies glucose for energy metabolism, so this term is defensible but represents a downstream physiological role rather than the core molecular/complex function of the regulatory alpha subunit. Retained as non-core.
|
|
GO:0036211
protein modification process
|
TAS
PMID:7549948 Isolation of cDNA encoding the human liver phosphorylase kin... |
MARK AS OVER ANNOTATED |
Summary: Author-statement involvement in protein modification process, referring to PhK's phosphorylation of its substrate (glycogen phosphorylase). This is a property of the catalytic gamma subunit and is an over-broad, over-attributed term for the regulatory alpha subunit.
Reason: Protein modification is what the holoenzyme's catalytic gamma subunit does (phosphorylating glycogen phosphorylase); assigning it to the non-catalytic alpha regulatory subunit both over-attributes the activity and is uninformatively broad. Marked as over-annotated.
Supporting Evidence:
file:human/PHKA2/PHKA2-uniprot.txt
Phosphorylase b kinase catalyzes the phosphorylation of
|
|
GO:0005980
glycogen catabolic process
|
TAS
Reactome:R-HSA-71588 |
NEW |
Summary: Proposed specific biological-process annotation: as a subunit of the cytosolic phosphorylase kinase complex, PHKA2 participates in glycogen catabolism (the complex phosphorylates glycogen phosphorylase to trigger glycogenolysis).
Reason: Captures the specific catabolic direction of PHKA2's glycogen-metabolic role, more precise than the existing carbohydrate/glycogen metabolic process annotations. Supported by Reactome curation of the hepatic glycogenolysis reaction catalyzed by the PhK complex containing PHKA2, and by the gene's loss-of-function disease (GSD IXa, a liver glycogenosis).
Supporting Evidence:
PMID:7549948
deficiency is the most frequent liver glycogen storage disease.
|
Q: Does the C-terminal cysteine of PHKA2 undergo farnesylation in vivo, and if so, does it target a fraction of the complex to membranes, or is the functionally dominant pool cytosolic?
Q: Which specific PKA (and autocatalytic) phosphorylation sites on the PHKA2 alpha subunit mediate activation of the holoenzyme, and how do GSD9A missense variants perturb this regulation versus simply destabilizing the complex?
Experiment: Reconstitute the liver holoenzyme with wild-type versus GSD9A-variant PHKA2 and measure Ca2+/calmodulin- and PKA-phosphorylation-dependent activation of glycogen phosphorylase to distinguish assembly defects from regulatory defects.
Experiment: Determine the subcellular distribution of endogenous PHKA2 in hepatocytes (cytosol versus membrane) and test whether inhibiting prenylation redistributes the complex.
UniProtKB: P46019 (KPB2_HUMAN). Gene: PHKA2 (synonyms PHKLA, PYK). X chromosome. 1235 aa.
PHKA2 encodes the liver isoform of the alpha regulatory subunit of phosphorylase kinase (PhK).
PhK is a large (alpha-beta-gamma-delta)4 hexadecameric holoenzyme:
- gamma (PHKG1 muscle / PHKG2 liver) is the catalytic subunit (a Ser/Thr protein kinase).
- alpha (PHKA1 muscle / PHKA2 liver) and beta (PHKB) are the large regulatory subunits.
- delta = calmodulin confers Ca2+ sensitivity.
UniProt SUBUNIT [file:human/PHKA2/PHKA2-uniprot.txt]:
"Hexadecamer of 4 heterotetramers, each composed of alpha, beta, gamma, and delta subunits. Alpha (PHKA1 or PHKA2) and beta (PHKB) are regulatory subunits, gamma (PHKG1 or PHKG2) is the catalytic subunit, and delta is calmodulin."
Therefore PHKA2 is NOT itself a protein kinase. Its own molecular role is regulatory: the alpha/beta subunits are the targets of cAMP-dependent (PKA) phosphorylation which, together with Ca2+/calmodulin, relieves the inhibition of the catalytic gamma subunit and activates the holoenzyme. UniProt ACTIVITY REGULATION: "By phosphorylation of various serine residues and by calcium." PHKA2 carries multiple experimentally-mapped phosphoserines in its C-terminal multiphosphorylation domain (Ser695, Ser729, Ser735, Ser983, Ser1015, Ser1044).
PhK phosphorylates glycogen phosphorylase (b -> a), triggering glycogenolysis (Reactome R-HSA-71588; R-HSA-70221 Glycogen breakdown). So PHKA2 is a structural/regulatory part of the complex that carries out the holoenzyme activity GO:0004689 phosphorylase kinase activity, but does not itself enable it.
UniProt FUNCTION: "Phosphorylase b kinase catalyzes the phosphorylation of serine in certain substrates, including troponin I. The alpha chain may bind calmodulin." Note this FUNCTION line describes the holoenzyme (PHK); the alpha chain's own contribution is calmodulin binding. Two Calmodulin-binding REGIONs are annotated (807-837, 1059-1099), and the KW list includes Calmodulin-binding.
Deficiency causes Glycogen storage disease type IXa / GSD9A (X-linked liver phosphorylase kinase deficiency) — MIM:306000, Orphanet 264580. Most common form of PhK deficiency. Hepatomegaly, growth retardation, usually mild and improving with age (often asymptomatic in adults). Two subtypes: type 1/classic (no PhK activity in liver AND erythrocytes) and type 2/variant (deficient in liver, normal in erythrocytes). Extensive allelic series of GSD9A missense/indel variants in UniProt.
[PMID:7549948 "X-linked liver glycogenosis (XLG) due to liver phosphorylase kinase (PHK)" ... "deficiency is the most frequent liver glycogen storage disease."; "We isolated and determined the structure of human liver alpha subunit of PHK (PHKA2) cDNA."; "a valine substitution for glycine at amino acid 193, in the PHKA2 gene of a family with XLG."]
enables; TAS PMID:7549948 enables): MARK_AS_OVER_ANNOTATED. This is the HOLOENZYME activity, catalyzed by the gamma subunit. PHKA2 as a regulatory subunit contributes to it but does not itself enable it. Not REMOVE — the essence (participation in the complex activity) is right, but enables on the alpha subunit over-attributes catalysis. In core_functions captured via contributes_to_molecular_function.id: P46019
gene_symbol: PHKA2
product_type: PROTEIN
status: INITIALIZED
taxon:
id: NCBITaxon:9606
label: Homo sapiens
description: >-
PHKA2 encodes the liver isoform of the alpha regulatory subunit of phosphorylase
kinase (PhK). PhK is a large hexadecameric (alpha-beta-gamma-delta)4 holoenzyme in
which the gamma subunit (PHKG1 in muscle, PHKG2 in liver) is the catalytic
serine/threonine kinase and the large alpha (PHKA1/PHKA2) and beta (PHKB) subunits
are regulatory; the delta subunit is calmodulin, conferring Ca2+ sensitivity. PHKA2
is itself non-catalytic: as a regulatory subunit it is a target of cAMP-dependent
(PKA) phosphorylation which, together with Ca2+/calmodulin, relieves inhibition and
activates the catalytic gamma subunit. The activated holoenzyme phosphorylates
glycogen phosphorylase (b to a), triggering glycogenolysis; PhK thereby couples
hormonal and neural signals to hepatic glycogen breakdown. PHKA2 binds calmodulin
and acts in the cytosol. Loss-of-function variants in PHKA2 cause X-linked liver
phosphorylase kinase deficiency (glycogen storage disease type IXa, GSD9A), the most
common form of PhK deficiency, characterized by hepatomegaly and growth retardation
that are usually mild and improve with age.
existing_annotations:
- term:
id: GO:0005964
label: phosphorylase kinase complex
evidence_type: IBA
original_reference_id: GO_REF:0000033
qualifier: part_of
review:
summary: >-
Phylogenetically inferred membership in the phosphorylase kinase complex. This
is the defining, core cellular-component assignment for PHKA2 as the liver alpha
regulatory subunit of the (alpha-beta-gamma-delta)4 holoenzyme.
action: ACCEPT
reason: >-
Strongly supported: PHKA2 is one of the alpha subunits of the phosphorylase
kinase holoenzyme. UniProt SUBUNIT describes the complex composition and assigns
alpha/beta as regulatory subunits, consistent with this IBA assignment.
supported_by:
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "beta, gamma, and delta subunits. Alpha (PHKA1 or PHKA2) and beta (PHKB)"
- term:
id: GO:0004689
label: phosphorylase kinase activity
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: enables
review:
summary: >-
ARBA electronic assertion that PHKA2 enables phosphorylase kinase activity. This
is the activity of the holoenzyme, catalyzed by the gamma subunit (PHKG1/PHKG2);
the alpha subunit is regulatory and non-catalytic.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The catalytic phosphorylase kinase activity resides in the gamma subunit, not the
alpha regulatory subunit. UniProt states that alpha and beta are regulatory
subunits while gamma is the catalytic subunit, so an 'enables' assertion of the
holoenzyme kinase activity on PHKA2 over-attributes catalysis to a regulatory
chain. PHKA2 contributes to this holoenzyme activity as a complex member (captured
in core_functions via contributes_to_molecular_function) but does not
independently enable it.
supported_by:
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "are regulatory subunits, gamma (PHKG1 or PHKG2) is the catalytic"
- term:
id: GO:0005516
label: calmodulin binding
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: enables
review:
summary: >-
InterPro-based assertion of calmodulin binding. This is a genuine molecular
function of the alpha subunit: UniProt notes the alpha chain may bind calmodulin
and annotates two calmodulin-binding regions (807-837, 1059-1099).
action: ACCEPT
reason: >-
Well supported and biologically informative for the alpha subunit. Consistent
with the Calmodulin-binding keyword and two annotated calmodulin-binding regions.
Calmodulin is the delta subunit of the complex, so alpha-CaM binding is
functionally central to Ca2+ regulation of the holoenzyme.
supported_by:
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "The alpha chain may"
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "bind calmodulin."
- term:
id: GO:0005737
label: cytoplasm
evidence_type: IEA
original_reference_id: GO_REF:0000117
qualifier: located_in
review:
summary: >-
ARBA electronic assertion of cytoplasmic localization. Correct but non-specific;
the more precise, curatorially supported location is the cytosol (GO:0005829).
action: ACCEPT
reason: >-
Cytoplasm is a correct broad parent of the cytosol, where the phosphorylase
kinase complex acts on cytosolic glycogen phosphorylase. Retained as a valid,
if less specific, location; the cytosol annotation is the more informative one.
- term:
id: GO:0005886
label: plasma membrane
evidence_type: IEA
original_reference_id: GO_REF:0000044
qualifier: located_in
review:
summary: >-
Subcellular-location keyword mapping (SL-0039) derived from UniProt's Cell
membrane assignment, which is itself an ECO:0000305 (inference from prenylation)
annotation, not an experimental localization.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The UniProt Cell membrane / Lipid-anchor location is an ECO:0000305 inference
resting on a possible C-terminal farnesyl-cysteine (itself by-similarity,
ECO:0000250), with the PTM note stating the terminal tripeptide is 'probably not
removed'. The functionally relevant and better-supported compartment is the
cytosol, where the complex phosphorylates cytosolic glycogen phosphorylase.
Retained but flagged as a weakly supported, likely over-annotated location.
supported_by:
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "SUBCELLULAR LOCATION: Cell membrane"
- term:
id: GO:0005975
label: carbohydrate metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000002
qualifier: involved_in
review:
summary: >-
InterPro-based involvement in carbohydrate metabolism. Correct but broad; PHKA2
participates specifically in glycogen catabolism as part of the phosphorylase
kinase complex.
action: ACCEPT
reason: >-
Accurate high-level biological-process assignment. The more specific glycogen
metabolic / glycogen catabolic terms better capture the function and are
reflected in core_functions, but this broad parent is not incorrect.
- term:
id: GO:0005977
label: glycogen metabolic process
evidence_type: IEA
original_reference_id: GO_REF:0000120
qualifier: involved_in
review:
summary: >-
Combined-IEA/UniPathway involvement in glycogen metabolism. Accurate: the
phosphorylase kinase complex regulates hepatic glycogenolysis, and PHKA2
deficiency causes a glycogen storage disease.
action: ACCEPT
reason: >-
Well aligned with the gene's biology. UniProt PATHWAY records glycogen
metabolism, and PHKA2 loss-of-function causes glycogen storage disease type IXa.
The catabolic direction is captured more specifically in core_functions.
supported_by:
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "PATHWAY: Glycan biosynthesis; glycogen metabolism."
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:23455922
qualifier: enables
review:
summary: >-
Bare protein-binding annotation from a large-scale AP-MS protein-complex
interlaboratory reproducibility study. Uninformative term with no specific,
functionally interpreted partner recorded.
action: MARK_AS_OVER_ANNOTATED
reason: >-
'Protein binding' (GO:0005515) is an uninformative molecular-function term. The
supporting reference is a high-throughput interactome dataset that does not
characterize a specific PHKA2 function; the biologically meaningful partners
(PHKG2, PHKB) are already captured by the phosphorylase kinase complex
annotation. Per curation policy this experimental IPI is marked as
over-annotated rather than removed.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:26496610
qualifier: enables
review:
summary: >-
Bare protein-binding annotation from a quantitative human-interactome study.
Uninformative term with no specific functional partner recorded.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative 'protein binding' term derived from a large-scale interactome
dataset. No specific PHKA2 function is established. Marked as over-annotated per
curation policy rather than removed.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:28514442
qualifier: enables
review:
summary: >-
Bare protein-binding annotation from a large-scale interactome/protein-community
study. Uninformative term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative 'protein binding' term from a high-throughput interactome dataset;
no specific PHKA2 molecular function is established. Marked over-annotated per
policy rather than removed.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32296183
qualifier: enables
review:
summary: >-
Bare protein-binding annotation from a binary (Y2H) reference-interactome map.
Uninformative term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative 'protein binding' term from a large-scale binary interactome
screen. No specific, functionally interpreted PHKA2 partner is captured beyond
complex membership already annotated elsewhere. Marked over-annotated per policy.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32707033
qualifier: enables
review:
summary: >-
Bare protein-binding annotation from a kinase-interaction-network study. The
relevant kinase partner (PHKG2, the catalytic gamma subunit) reflects complex
membership, but the bare term itself is uninformative.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative 'protein binding' term. The functionally meaningful interaction
(with the catalytic gamma subunit PHKG2) is captured by the phosphorylase kinase
complex annotation; the bare MF term adds nothing. Marked over-annotated per
policy rather than removed.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:32814053
qualifier: enables
review:
summary: >-
Bare protein-binding annotation from a neurodegenerative-disease interactome
mapping study (partner SPRED1). Uninformative term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative 'protein binding' term from a high-throughput interactome dataset;
the SPRED1 interaction is not functionally interpreted for PHKA2. Marked
over-annotated per policy rather than removed.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:33961781
qualifier: enables
review:
summary: >-
Bare protein-binding annotation from a proteome-scale, cell-specific interactome
study. Uninformative term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative 'protein binding' term from a large-scale interactome dataset; no
specific PHKA2 function is established. Marked over-annotated per policy.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:35271311
qualifier: enables
review:
summary: >-
Bare protein-binding annotation from the OpenCell endogenous-tagging cellular
cartography study. Uninformative term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative 'protein binding' term from a high-throughput cellular-organization
dataset; no specific PHKA2 molecular function is established. Marked over-annotated
per policy rather than removed.
- term:
id: GO:0005515
label: protein binding
evidence_type: IPI
original_reference_id: PMID:40205054
qualifier: enables
review:
summary: >-
Bare protein-binding annotation from a multimodal cell-maps structural/functional
genomics study. Uninformative term.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Uninformative 'protein binding' term from a large-scale cell-mapping dataset; no
specific PHKA2 function is established. Marked over-annotated per policy rather
than removed.
- term:
id: GO:0005964
label: phosphorylase kinase complex
evidence_type: IEA
original_reference_id: GO_REF:0000107
qualifier: part_of
review:
summary: >-
Ensembl-Compara orthology transfer of experimentally verified phosphorylase
kinase complex membership. Consistent with the core complex assignment.
action: ACCEPT
reason: >-
Correct and well supported; the same defining complex membership as the IBA and
TAS annotations. PHKA2 is the liver alpha regulatory subunit of the holoenzyme.
supported_by:
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "Hexadecamer of 4 heterotetramers, each composed of alpha,"
- term:
id: GO:0005829
label: cytosol
evidence_type: TAS
original_reference_id: Reactome:R-HSA-71588
qualifier: located_in
review:
summary: >-
Reactome-curated cytosolic localization. The cytosolic phosphorylase kinase
complex phosphorylates cytosolic glycogen phosphorylase (PYGL) in liver. This is
the core, functionally relevant location for PHKA2.
action: ACCEPT
reason: >-
Well supported by Reactome curation of the hepatic glycogenolysis reaction; the
complex containing PHKA2 acts in the cytosol. This is the preferred location over
the by-similarity plasma-membrane assignment.
- term:
id: GO:0004689
label: phosphorylase kinase activity
evidence_type: TAS
original_reference_id: PMID:7549948
qualifier: enables
review:
summary: >-
Author-statement (TAS) assignment of phosphorylase kinase activity from the paper
cloning the human liver PHKA2 alpha subunit. The described activity is that of the
PhK holoenzyme, catalyzed by the gamma subunit; the alpha subunit is regulatory.
action: MARK_AS_OVER_ANNOTATED
reason: >-
The cited paper isolates and characterizes the liver alpha subunit and discusses
liver phosphorylase kinase (the holoenzyme), but the catalytic activity resides in
the gamma subunit. Assigning 'enables phosphorylase kinase activity' to the
regulatory alpha subunit over-attributes catalysis. PHKA2 contributes to this
holoenzyme activity as a complex member (contributes_to_molecular_function in
core_functions) but does not independently enable it.
supported_by:
- reference_id: PMID:7549948
supporting_text: "We isolated and determined the structure of human liver alpha subunit of PHK (PHKA2) cDNA."
- term:
id: GO:0005964
label: phosphorylase kinase complex
evidence_type: TAS
original_reference_id: PMID:7549948
qualifier: part_of
review:
summary: >-
Author-statement (TAS) assignment of phosphorylase kinase complex membership from
the paper cloning the human liver PHKA2 alpha subunit. Core complex membership.
action: ACCEPT
reason: >-
Directly supported: the reference characterizes PHKA2 as the human liver alpha
subunit of phosphorylase kinase, establishing its membership in the holoenzyme
complex.
supported_by:
- reference_id: PMID:7549948
supporting_text: "We isolated and determined the structure of human liver alpha subunit of PHK (PHKA2) cDNA."
- term:
id: GO:0005975
label: carbohydrate metabolic process
evidence_type: TAS
original_reference_id: PMID:7549948
qualifier: involved_in
review:
summary: >-
Author-statement involvement in carbohydrate metabolism. Correct but broad; the
specific process is glycogen catabolism via the phosphorylase kinase complex.
action: ACCEPT
reason: >-
Accurate high-level assignment supported by the paper's framing of PHKA2 in liver
glycogenosis. More specific glycogen catabolic terms are captured in
core_functions, but this broad parent is not incorrect.
supported_by:
- reference_id: PMID:7549948
supporting_text: "deficiency is the most frequent liver glycogen storage disease."
- term:
id: GO:0006091
label: generation of precursor metabolites and energy
evidence_type: TAS
original_reference_id: PMID:7549948
qualifier: involved_in
review:
summary: >-
Author-statement involvement in generation of precursor metabolites and energy.
This reflects the downstream role of hepatic glycogenolysis in supplying glucose
for energy, an indirect/downstream consequence rather than PHKA2's core function.
action: KEEP_AS_NON_CORE
reason: >-
Glycogenolysis driven by the phosphorylase kinase complex ultimately supplies
glucose for energy metabolism, so this term is defensible but represents a
downstream physiological role rather than the core molecular/complex function of
the regulatory alpha subunit. Retained as non-core.
- term:
id: GO:0036211
label: protein modification process
evidence_type: TAS
original_reference_id: PMID:7549948
qualifier: involved_in
review:
summary: >-
Author-statement involvement in protein modification process, referring to PhK's
phosphorylation of its substrate (glycogen phosphorylase). This is a property of
the catalytic gamma subunit and is an over-broad, over-attributed term for the
regulatory alpha subunit.
action: MARK_AS_OVER_ANNOTATED
reason: >-
Protein modification is what the holoenzyme's catalytic gamma subunit does
(phosphorylating glycogen phosphorylase); assigning it to the non-catalytic alpha
regulatory subunit both over-attributes the activity and is uninformatively broad.
Marked as over-annotated.
supported_by:
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "Phosphorylase b kinase catalyzes the phosphorylation of"
- term:
id: GO:0005980
label: glycogen catabolic process
evidence_type: TAS
original_reference_id: Reactome:R-HSA-71588
qualifier: involved_in
review:
summary: >-
Proposed specific biological-process annotation: as a subunit of the cytosolic
phosphorylase kinase complex, PHKA2 participates in glycogen catabolism (the
complex phosphorylates glycogen phosphorylase to trigger glycogenolysis).
action: NEW
reason: >-
Captures the specific catabolic direction of PHKA2's glycogen-metabolic role,
more precise than the existing carbohydrate/glycogen metabolic process
annotations. Supported by Reactome curation of the hepatic glycogenolysis
reaction catalyzed by the PhK complex containing PHKA2, and by the gene's
loss-of-function disease (GSD IXa, a liver glycogenosis).
supported_by:
- reference_id: PMID:7549948
supporting_text: "deficiency is the most frequent liver glycogen storage disease."
core_functions:
- description: >-
As the liver alpha regulatory subunit, PHKA2 binds calmodulin (the delta subunit)
and is a component of the phosphorylase kinase holoenzyme, contributing to its
Ca2+- and phosphorylation-regulated phosphorylase kinase activity while being itself
non-catalytic. Through the complex it drives cytosolic glycogen catabolism.
molecular_function:
id: GO:0005516
label: calmodulin binding
contributes_to_molecular_function:
id: GO:0004689
label: phosphorylase kinase activity
directly_involved_in:
- id: GO:0005980
label: glycogen catabolic process
in_complex:
id: GO:0005964
label: phosphorylase kinase complex
locations:
- id: GO:0005829
label: cytosol
supported_by:
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "are regulatory subunits, gamma (PHKG1 or PHKG2) is the catalytic"
- reference_id: file:human/PHKA2/PHKA2-uniprot.txt
supporting_text: "The alpha chain may"
- reference_id: PMID:7549948
supporting_text: "deficiency is the most frequent liver glycogen storage disease."
proposed_new_terms: []
suggested_questions:
- question: >-
Does the C-terminal cysteine of PHKA2 undergo farnesylation in vivo, and if so, does
it target a fraction of the complex to membranes, or is the functionally dominant
pool cytosolic?
- question: >-
Which specific PKA (and autocatalytic) phosphorylation sites on the PHKA2 alpha
subunit mediate activation of the holoenzyme, and how do GSD9A missense variants
perturb this regulation versus simply destabilizing the complex?
suggested_experiments:
- description: >-
Reconstitute the liver holoenzyme with wild-type versus GSD9A-variant PHKA2 and
measure Ca2+/calmodulin- and PKA-phosphorylation-dependent activation of glycogen
phosphorylase to distinguish assembly defects from regulatory defects.
- description: >-
Determine the subcellular distribution of endogenous PHKA2 in hepatocytes (cytosol
versus membrane) and test whether inhibiting prenylation redistributes the complex.
references:
- id: GO_REF:0000002
title: Gene Ontology annotation through association of InterPro records with GO
terms
findings: []
- id: GO_REF:0000033
title: Annotation inferences using phylogenetic trees
findings: []
- id: GO_REF:0000044
title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
vocabulary mapping, accompanied by conservative changes to GO terms applied by
UniProt
findings: []
- id: GO_REF:0000107
title: Automatic transfer of experimentally verified manual GO annotation data to
orthologs using Ensembl Compara
findings: []
- id: GO_REF:0000117
title: Electronic Gene Ontology annotations created by ARBA machine learning models
findings: []
- id: GO_REF:0000120
title: Combined Automated Annotation using Multiple IEA Methods
findings: []
- id: file:human/PHKA2/PHKA2-uniprot.txt
title: UniProtKB entry P46019 (KPB2_HUMAN), Phosphorylase b kinase regulatory subunit
alpha, liver isoform
findings: []
- id: PMID:23455922
title: Interlaboratory reproducibility of large-scale human protein-complex analysis
by standardized AP-MS.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
High-throughput AP-MS dataset underpinning a bare protein-binding IPI; no
PHKA2-specific function established.
- id: PMID:26496610
title: A human interactome in three quantitative dimensions organized by stoichiometries
and abundances.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large-scale quantitative interactome dataset; source of a bare protein-binding IPI.
- id: PMID:28514442
title: Architecture of the human interactome defines protein communities and disease
networks.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Large-scale interactome/community dataset; source of a bare protein-binding IPI.
- id: PMID:32296183
title: A reference map of the human binary protein interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Binary (Y2H) reference-interactome dataset; source of bare protein-binding IPIs.
- id: PMID:32707033
title: Kinase Interaction Network Expands Functional and Disease Roles of Human
Kinases.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Kinase-interaction-network dataset; the meaningful partner (catalytic gamma
subunit PHKG2) reflects complex membership already captured elsewhere.
- id: PMID:32814053
title: Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins
and Uncovers Widespread Protein Aggregation in Affected Brains.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Neurodegenerative-disease interactome dataset; source of a bare protein-binding
IPI (SPRED1), not functionally interpreted for PHKA2.
- id: PMID:33961781
title: Dual proteome-scale networks reveal cell-specific remodeling of the human
interactome.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Proteome-scale interactome dataset; source of a bare protein-binding IPI.
- id: PMID:35271311
title: 'OpenCell: Endogenous tagging for the cartography of human cellular organization.'
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Endogenous-tagging cellular-organization dataset; source of a bare protein-binding
IPI.
- id: PMID:40205054
title: Multimodal cell maps as a foundation for structural and functional genomics.
findings: []
reference_review:
relevance: LOW
correctness: VERIFIED
review_notes: >-
Multimodal cell-mapping dataset; source of a bare protein-binding IPI.
- id: PMID:7549948
title: Isolation of cDNA encoding the human liver phosphorylase kinase alpha subunit
(PHKA2) and identification of a missense mutation of the PHKA2 gene in a family
with liver phosphorylase kinase deficiency.
findings: []
reference_review:
relevance: HIGH
correctness: VERIFIED
review_notes: >-
Abstract-only cache. Directly establishes PHKA2 as the human liver alpha subunit
of phosphorylase kinase and links it to X-linked liver PhK deficiency (GSD IXa);
basis for the TAS complex/activity/process annotations.
- id: Reactome:R-HSA-71588
title: glycogen phosphorylase (PYGL) dimer b + 2 ATP => glycogen phosphorylase (PYGL)
dimer a + 2 ADP
findings: []